2m 2m 2m 2m 2m 2m 2m
Vertex Pharma (VRTX)
NASDAQ
$480.98-$4.41 (-0.91%)
Price as of Jul 13, 2026 7:59 PM EDT- $123.2BMarket Cap
- 3.53%1-Year Change
- BiotechnologyIndustry
Vertex Pharma (VRTX)
$480.98-$4.41 (-0.91%)
VRTX | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $485.39 | ||
Change | -$11.11 (-2.24%) | ||
Open | $498.15 | ||
High | $498.91 | ||
Low | $484.33 | ||
Previous Close | $485.39 | ||
Volume | 1,153,856 | ||
30-Day Average Volume | 2,023,986 | ||
1-Week Change | -8.08% | ||
1-Month Change | 11.40% | ||
1-Year Change | 3.53% | ||
3-Year Change | 40.91% | ||
5-Year Change | 144.95% | ||
Fundamentals | |||
Shares Outstanding | 253.8M | ||
Total Assets | $26.5B | ||
Market Cap | $123.2B | ||
Enterprise Value | $117.7B | ||
Period: QTR TTM FY | |||
Revenue | $3.0B | ||
Net Income | $1.0B | ||
Free Cash Flow | $1.3B | ||
EBIT | $1.3B | ||
EBITDA | $1.3B | ||
Net Working Capital | $7.8B | ||
EPS | $4.02 | ||
Enterprise Value/EBITDA | 90 | ||
Enterprise Value/Revenue | 39 | ||
P/B | 6 | ||
P/E | 121 | ||
PEG | -9 | ||
Price/Free Cash Flow | 95 | ||
Price/Operating Cash Flow | 86 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue